3,888
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

The severity of dissociative symptoms among patients with cannabis and synthetic cannabinoid use disorder: association with substance use characteristics and suicide

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 603-608 | Received 15 May 2018, Accepted 24 Jul 2018, Published online: 03 Aug 2018

References

  • UNODC. World Drug Report. World Drug Report; 2009.
  • European Monitoring Centre for Drugs and Drug Addiction. The EMCDDA annual report 2010: the state of the drugs problem in Europe. Lisbon: EMCDDA; 2016. (European Drug Report).
  • Wells DL, Ott CA. The “new” marijuana. Ann Pharmacother. 2011;45(3):414–417. doi: 10.1345/aph.1P580
  • Heath TS, Burroughs Z, Thompson AJ, et al. Acute intoxication caused by a synthetic cannabinoid in two adolescents. J Pediatr Pharmacol Ther. 2012;17(2):177–181.
  • Winstock AR, Barratt MJ. Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug Alcohol Depend. 2013;131(1–3):106–111. doi: 10.1016/j.drugalcdep.2012.12.011
  • Johnston LD, O’Malley PM, Miech RA, et al. Monitoring the future national survey results on drug use: 1975–2013: overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research, The University of Michigan; 2014.
  • Castaneto MS, Gorelick DA, Desrosiers NA, et al. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug and Alcohol Depend. 2014;144:12–41. doi: 10.1016/j.drugalcdep.2014.08.005
  • Schneir AB, Cullen J, Ly BT. “Spice” girls: synthetic cannabinoid intoxication. J Emerg Med. 2011;40(3):296–299. doi: 10.1016/j.jemermed.2010.10.014
  • Atwood BK, Huffman J, Straiker A, et al. JWH018, a common constituent of “spice” herbal blends, is a potent and efficacious cannabinoid CB1 receptor agonist. Br J Pharmacol. 2010;160(3):585–593. doi: 10.1111/j.1476-5381.2009.00582.x
  • European Monitoring Centre for Drugs and Drug Addiction. Understanding the Spice Phenomenon. Themat Pap [Internet]. 2009;25. Available from: http://www.emcdda.europa.eu/publications/thematic-papers/spice.
  • Zimmermann US, Winkelmann PR, Pilhatsch M, et al. Withdrawal phenomena and dependence syndrome after the consumption of “spice gold”. Dtsch Ärzteblatt Int [Internet]. 2009;106(27):464–467. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2719097&tool=pmcentrez&rendertype=abstract.
  • Gunderson EW, Haughey HM, Ait-Daoud N, et al. “Spice” and “k2” herbal highs: A case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. Am J Addict. 2012;21(4):320–326. doi: 10.1111/j.1521-0391.2012.00240.x
  • Dunn GE, Paolo AM, Ryan JJ, et al. Dissociative symptoms in a substance abuse population. Am J Psychiatry. 1993;150(7):1043–1047. doi: 10.1176/ajp.150.7.1043
  • Wenzel K, Bernstein DP, Handelsman L, et al. Levels of dissociation in detoxified substance abusers and their relationship to chronicity of alcohol and drug use. J Nerv Ment Dis. 1996;184(4):220–227. doi: 10.1097/00005053-199604000-00004
  • Dadi G, Dervaux A, Krebs MO, et al. Persistent depersonalization/derealization disorder induced by synthetic cannabinoids. Am J Psychiatry. 2016;173(8):839–840. doi: 10.1176/appi.ajp.2016.16010029
  • Evren C, Ogel K. Dissociative symptoms among alcohol and substance dependents and its relationships with childhood trauma history, depression, anxiety, and alcohol/substance use. Anadolu Psikiyatr Derg. 2003;4(1):30–37.
  • Tamar-Gurol D, Sar V, Karadag F, et al. Childhood emotional abuse, dissociation, and suicidality among patients with drug dependency in Turkey. Psychiatry Clin Neurosci. 2008;62(5):540–547. doi: 10.1111/j.1440-1819.2008.01847.x
  • Evren C, Sar V, Karadag F, et al. Dissociative disorders among alcohol-dependent inpatients. Psychiatry Res. 2007;152(2–3):233–241. doi: 10.1016/j.psychres.2005.08.004
  • Kaplan ML, Erensaft M, Sanderson WC, et al. Dissociative symptomatology and aggressive behavior. Compr Psychiatry. 1998;39(5):271–276. doi: 10.1016/S0010-440X(98)90035-9
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th Edition (DSM-5). Diagnostic Stat Man Ment Disord 4th Ed TR. 2013;280.
  • Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis. 1986;174(12):727–735. doi: 10.1097/00005053-198612000-00004
  • Yargiç LI, Şar V, Tutkun H, et al. Comparison of dissociative identity disorder with other diagnostic groups using a structured interview in Turkey. Compr Psychiatry. 1998;39(6):345–351. doi: 10.1016/S0010-440X(98)90046-3
  • Hodgins DC, Pennington M, el-Guebaly N, et al. Correlates of dissociative symptoms in substance abusers. J Nerv Ment Dis. 1996;184(10):636–639. doi: 10.1097/00005053-199610000-00009
  • Vandrey R, Dunn KE, Fry JA, et al. A survey study to characterize use of spice products (synthetic cannabinoids). Drug Alcohol Depend. 2012;120(1–3):238–241. doi: 10.1016/j.drugalcdep.2011.07.011
  • Jerry J, Collins G, Streem D. Synthetic legal intoxicating drugs: the emerging “incense” and “bath salt” phenomenon. Cleve Clin J Med. 2012;79(4):258–264. doi: 10.3949/ccjm.79a.11147
  • Cavaiola AA, Lavender N. Suicidal behavior in chemically dependent adolescents. Adolescence. 1999;34(136):735–744.
  • Kaplan ML, Asnis GM, Lipschitz DS, et al. Suicidal behavior and abuse in psychiatric outpatients. Compr Psychiatry. 1995;36(3):229–235. doi: 10.1016/0010-440X(95)90087-C
  • Calati R, Bensassi I, Courtet P. The link between dissociation and both suicide attempts and non-suicidal self-injury: meta-analyses. Psychiatry Res. 2017;251:103–114. doi: 10.1016/j.psychres.2017.01.035